CVRx (CVRX) vs DarioHealth (DRIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
DarioHealth (DRIO) has outperformed CVRx (CVRX) over the past year, losing 60.9% versus a loss of 81.6%. Over five years, CVRX leads with a -89.3% price change compared with -98.3% for DRIO. DarioHealth is the larger company by market cap ($53.2 million vs $44.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVRX | DRIO |
|---|---|---|
| Share price | $1.68 | $5.43 |
| Market cap | $44.76M | $53.21M |
| 1-day change | +0.60% | -10.69% |
| YTD return | -76.34% | -46.57% |
| 1-year return | -81.56% | -60.90% |
| 5-year return | -89.27% | -98.32% |
| EPS (TTM) | $-1.97 | $-2.28 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.30 | $16.55 |
| 52-week low | $1.50 | $5.43 |
| Distance from 52-week high | -85.13% | -67.19% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +172.62% | +150.46% |
| Average volume | 917.19K | 24.43K |
| Shares outstanding | 26.64M | 9.80M |
| Employees | 223 | 160 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Health Information Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DRIO has outperformed CVRX by 20.7 percentage points over the past year.
About CVRx
CVRX stock →CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system.
Healthcare · Medical Devices · 223 employees
About DarioHealth
DRIO stock →DarioHealth Corp. operates as a digital health company in the United States and internationally.
Healthcare · Health Information Services · 160 employees
CVRX vs DRIO FAQ
Which is bigger, CVRx or DarioHealth?
DarioHealth (DRIO) is larger, with a market capitalization of $53.21M compared with $44.76M for CVRx (CVRX).
Which stock has performed better over the past year, CVRX or DRIO?
DRIO returned -60.90% over the past 12 months, compared with -81.56% for CVRX (price return, excluding dividends). Past performance does not predict future results.
Are CVRx and DarioHealth in the same industry?
Both are in the Healthcare sector, but in different industries: Medical Devices for CVRx and Health Information Services for DarioHealth.